Apellis Pharmaceuticals shares owned by Ensign Peak Advisors
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Ensign Peak Advisors
from 13F filings
Historical chart of Ensign Peak Advisors investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Ensign Peak Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $375k | 17k | 22.63 |
| 2025-06-30 | $509k | 29k | 17.31 |
| 2025-03-31 | $643k | 29k | 21.87 |
| 2024-12-31 | $2.5M | 79k | 31.91 |
| 2024-09-30 | $2.3M | 81k | 28.84 |
| 2024-06-30 | $3.2M | 83k | 38.36 |
| 2024-03-31 | $15M | 260k | 58.78 |
| 2023-09-30 | $7.1M | 186k | 38.04 |
| 2023-06-30 | $2.8M | 31k | 91.10 |
| 2023-03-31 | $2.0M | 30k | 65.96 |
| 2022-12-31 | $8.5M | 163k | 51.71 |
| 2022-09-30 | $1.5M | 22k | 68.29 |
| 2022-06-30 | $6.3M | 140k | 45.22 |
| 2022-03-31 | $2.0M | 40k | 50.80 |
| 2021-12-31 | $4.0M | 86k | 47.28 |
| 2021-09-30 | $97k | 2.9k | 32.97 |
| 2021-06-30 | $3.0M | 47k | 63.19 |
| 2021-03-31 | $1.8M | 43k | 42.90 |
| 2020-12-31 | $2.4M | 43k | 57.19 |
| 2020-09-30 | $1.1M | 35k | 30.19 |
| 2020-06-30 | $802k | 25k | 32.67 |
| 2020-03-31 | $206k | 7.7k | 26.77 |
| 2019-12-31 | $314k | 10k | 30.70 |